I.M.C.I. - Innovation in Patient - Centered Multimodality Cardiac Imaging

I.M.C.I. was born in COVID-19 era and developed in line with pandemia’s restrictions. Despite the limitations we took this condition as an opportunity. Starting from the framework of three congresses we launched previously, 3D Echo 360, Milan Cardiac Imaging and Innovations in Cardiology, we designed a sensational structure for a planetary event with the support of a superb international panel of experts.

The course includes 12 sessions, 90 minutes each, and will be broadcast starting 1.00 pm UTC+1 on the following dates:

  • June 4, 11, 18, 25
  • July 2, 9, 16, 23
  • September 3, 10, 17, 24

To meet the different educational expectations of all attendees we conceived multiple educational offerings by planning the main course as live and on demand streaming and online hands-on training sessions.

Duration:  1080 min

Course Description

Cardiovascular diseases are the leading cause of death in the western world. Parallel to advances in patient care, there is a deep revolution in the field of diagnostics for the whole spectrum of heart diseases. Currently, there is awareness of the exceptional recent spread of "new" diagnostic tools

able to drive the right therapeutic approach. In this context, the course deals with state-of-art of diagnostics in cardiology even through integration with the multiple branches of cardiology and with the therapeutic approach. It is proposed as an open and interesting forum for sharing experiences and developing highly educational paths thanks to the active participation and fervent support of a superb international panel of experts. The main topics are represented by valvular diseases, infective endocarditis, stable coronary artery diseases, hypertension mediated organ damage, electrophysiology and cardiac electrostimulation, cardiomyopathies, sport, and artificial intelligence.

On the other hand, it is equally true that technological development runs at a higher pace compared to the capacity to fully exploit its potential. All diagnostics employed in cardiac field have been leaving a fast growth guided by an efficient interplay with positive implications on cardiac disease overview, diagnosis, and treatment. This is true for two-dimensional (2D), spectral and color Doppler, tissue Doppler, real-time three-dimensional (3D) transthoracic and transesophageal, speckle tracking techniques which traced the remarkable history of innovation in echocardiography, for nuclear cardiology which have revealed details on the basic pathophysiology of ischemic heart diseases and holds unique capability of absolute myocardial blood flow estimation, for cardiac magnetic resonance and its 3D full volume acquisition, T1 and T2 mapping sequences and the so splendid 4D flow cine, and for cardiac computed tomography where coronary plaque imaging has reached high levels of detail and where stress technique and derived functional information go beyond what we could imagine only few years ago. With this in mind, this course has the main purpose to contribute to the cultural growth necessary for a rational and effective clinical application of the new technologic armamentarium.

Live Streaming

  • 1. Multimodality imaging in patients with severe aortic valve stenosis

    90 min.

    Multimodality imaging in patients with severe aortic valve stenosis

    Moderators: Chiara Bucciarelli-Ducci (Bristol, UK), Randy Martin (Atlanta, US)

    • Pitfalls of echocardiographic evaluation of aortic stenosis severity
      Mauro Pepi (Milan, IT)
    • Stress-echo evaluation of low-gradient severe aortic stenosis
      Hung Judy (Boston, US)
    • Multidetector CT to assess the severity of aortic stenosis
      Clavel Marie (Quebec, CA)
    • The role of CMR in asymptomatic patients with severe aortic stenosis
      Pibarot Philippe (Quebec, CA)

  • 2. Multimodality imaging to assess patients with functional tricuspid regurgitation

    90 min.

    Moderators: Karima Addetia (Chiacago, US), Eustachio Agricola (Milan, IT)

    • The role of advanced echocardiography to understand the pathophysiology of FTR
      Denisa Muraru (Milan, IT)
    • How to assess the severity of functional tricuspid regurgitation
      Luigi P. Badano (Milan, IT)
    • The role of CT to select patients for transcatheter interventions
      Victoria Delgado (Leiden, NL)
    • When do we need CMR?
      Zoghbi William (Houston, US)

  • 3. Multimodality imaging to assess patients with functional mitral regurgitation

    90 min.

    Moderators: Chiara Bucciarelli Ducci (London, UK), Francesco Maisano (Zurich, CH)

    • The role of advanced echocardiography to assess the pathophysiology and severity of functional MR
      Valentina Volpato (Milan, IT)
    • Cardiac magnetic resonance to assess cardiac remodeling and severity of the regurgitation
      Joao l. Cavalcante (Minneapolis, US)
    • Cardiac CT to select patients for transcatheter repair
      Niccolò Piazza (Montreal, CA)

  • 4. Mitral annulus disjunction: A possible mechanism for ventricular arrhythmias in Mitral Valve Prolapse

    90 min.

    Moderators: Alex P.W. Lee (Hong Kong, CN), Cristina Basso (Padua, IT)

    • From mid-systolic click to ventricular arrhythmias
      S. Iliceto (Padua, IT)
    • Annuls disjunction: from an abnormal movement to myocardial scar
      Alex P.W. Lee (Hong Kong, CN)
    • Myocardial ethereogeneicity and severe ventricular arrhythmias
      M. Perazzolo-Marra (Padua, IT)
    • Annulus disjunction without mitral valve prolapse
      Kristina Haugaa (Oslo, NO)

  • 5. Stable coronary artery disease

    90 min.

    Moderators: Steffen Petersen (London, UK), Gianluca Pontone (Milan, IT)

    • CT for prognostic stratification
      Leesle Shaw (New York, US)
    • CT assessment of coronary inflammation: from methodology to prognostic impact
      Day Damini (Los Angeles, US)
    • Myocardial flow reserve for coronary stenosis severity assessment: CMR or CT?
      Gianluca Pontone (Milan, IT)
    • Myocardial flow reserve in X syndrome
      Danilo Neglia (Pisa, IT)

  • 6. Imaging and Arrhythmias

    90 min.

    Moderators: Chiara Bucciarelli-Ducci (London, UK), Stefano Favale (Bari, IT)

    • Expecting significant improvement in LVEF after CRT: let imaging guide us!
      Jens Uwe Voigt (Leuven, BE)
    • Do we need a cardiac MR in HF patients with NON-Ischemic Cardiomyopathy undergoing primary prevention ICD implantation?
      Andrea I. Guaricci (Bari, IT)
    • Do we need a cardiac MR in HF patients with Ischemic Cardiomyopathy undergoing primary prevention ICD implantation
      Anna Baritussio (Padua, IT)
    • I123-MIBG to identify high risk patients
      Alessia Gimelli (Pisa, IT)

  • 7. Innovation in Cardiomyopathies

    90 min.

    Moderators: Matteo Cameli (Siena, IT), Sabino Iliceto (Padua, IT)

    • Which diagnostic workflow is appropriate in suspected Takotsubo Syndrome
      Rodolfo Citro (Salerno, IT)
    • The diagnostic approach to HCM and differential diagnosis with other diseases with similar phenotype
      Lia Crotti (Milan, IT)
    • How to interpret information derived by cardiac MR in the broad spectrum of restrictive cardiomyophaties
      Jeanette Schulz-Menger (Berlin, DE)
    • SGLT2 inhibitor in chronic heart failure: which drug in which patient
      Marco Metra (Brescia, IT)

  • 8. Cardiac diagnostics at the service of Sport

    90 min.

    Moderators: Massimo Francesco Piepoli (Piacenza, IT), Andre La Gerche (Melbourn, AU)

    • From the screening ECG to the cardiac MR: when a mandatory step?
      Sanjay Sharma (London, UK)
    • The coronary anomalies: is it possible to avoid the irreparable?
      Flavio d'Ascenzi (Siena, IT)
    • Athlete’s heart vs heart disease: the role of imaging in a sports cardiology dilemma
      Sabiha Gati (London, UK)
    • How to manage the blood pressure changes at high altitude
      Gianfranco Parati (Milan, IT)

  • 9. From the clinical suspicion to the diagnostic work-flow in patients with ventricular arrhythmias (CASE-BASED session how clinical/ECG red flags address the diagnostic workflow)

    90 min.

    Moderators: Moderator: G. Pontone (Milan, IT), Marianna Fontana (London, UK)

    • When to start with an imaging in case of ventricular extrasistolia?
      Antonio Dello Russo (Ancona, IT)
    • Which imaging pathway in case of dilated cardiac phenotype
      Edoardo Conte (Milan, IT)
    • Which imaging pathway in case of hypertrophic cardiac phenotype
      Marianna Fontana (London, UK)
    • VT procedure ablation imaging guided: CT or MR
      Corrado Carbucicchio (Milan, IT)

  • 10. Multimodality imaging to assess patients with infective endocarditi

    90 min.

    Multimodality imaging to assess patients with infective endocarditis
    Moderators: Elif Sade (Istambul, TR)

    • Transthoracic and transesophageal echocardiography. When and in whom?
      Giuseppe Trocino (Monza, IT)
    • 18F- fluorodeoxyglucose PET-CT in difficult patient
      Riemer Slart (Groningen, NL)
    • 99mTc-HMPAO labeled leukocite scintigraphy in the diagnosis of cardiac device-related infective endocarditis
      Paola Erba (Pisa, IT)
    • Incremental value of multimodality imaging in the evaluation of complicated prosthetic valve endocarditis
      Marc Dweck (Edinburgh, UK)

  • 11. Artificial Intelligence in Cardiology

    90 min.

    Artificial Intelligence in Cardiology

    Moderators: Daniela Besozzi (Milan, IT), Mattia Chiesa (Milan, IT)

    • Artificial intelligence made easy for phisicians
    Gianluca Pontone (Milan, IT)

    • Which role in Echo
    Federico M. Asch (Washington, US)

    • Which role in CT
    Carlo De Cecco (Atlanta, US)

    • Which role in MR
    Marco Francone (Milan, IT)

  • 12. Cardiovascular Imaging in Assessing Hypertension Mediated Organ Damage

    90 min.

    Cardiovascular Imaging in Assessing Hypertension Mediated Organ Damage
    Moderators: Gianfranco Parati (Milan, IT), Thomas Kahan (Stokholm, SW)

    • The assessment of cardiac damage. Perpsectives from echocardiograhy and magnetic resonance imaging
      Giovanni de Simone (Naples, IT)
    • The assessment of vascular damage through Doppler ultrasound imaging
      Maria Lorenza Muiesan (Brescia, IT)
    • The assessment of changes in arterial wall properties with magnetic resonance imaging
      Thomas Weber (Wels, AT)
    • Sex differences in hypertension mediated organ damage as assessed by different imaging techniques
      Eva Gerdts (Bergen, NO)